Glioblastoma multiforme in a case of acquired immunodeficiency syndrome: Investigating a possible oncogenic influence of human immunodeficiency virus on glial cells

Journal of Neurosurgery

Volumn 92, Issue 1, 2000, Pages 161-164

  Vannemreddy, Prasad S S V ^a   Fowler, Marjorie ^a   Polin, Richard S ^a   Todd, John R ^a   Nanda, Anil ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

Acquired immunodeficiency syndrome; Glioma; Human immunodeficiency virus; Infection; Lymphoma; Toxoplasma

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADJUVANT THERAPY; ADULT; ARTICLE; BRAIN BIOPSY; CASE REPORT; CENTRAL NERVOUS SYSTEM; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; GLIA CELL; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MALE; PRIORITY JOURNAL; RADIODIAGNOSIS; STEREOTAXIC SURGERY; TOXOPLASMA;

EID: 0033966532     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2000.92.1.0161     Document Type: Article

References (29)

1. Ammassari A, Scoppettuolo G, Murri R, et al: Changing disease patterns in focal brain lesion-causing disorders in AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 18:365-371, 1998
2. Antinori A, Ammassari A, De Luca A, et al: Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF. Neurology 48: 687-694, 1997
3. Antinori A, De Rossi G, Ammassari A, et al: Value of combined approach with thallium-201 single-photon emission computed tomography and Epstein-Barr virus DNA polymerase chain reaction in CSF for the diagnosis of AIDS-related primary CNS lymphoma. J Clin Oncol 17:554-560, 1999
4. Balzarini J, Sobis H, Naesens L, et al: Inhibitory effects of 9-(2-phosphonylmethoxyethyl)adenine and 3′-azido-2′,3′-dideoxy-thymidine on tumor development in mice inoculated intracerebrally with Moloney murine sarcoma virus. Int J Cancer 45: 486-489, 1990
5. Chamberlain MC: Gliomas in patients with acquired immune deficiency syndrome. Cancer 74:1912-1914, 1994
6. Cheng-Mayer C, Rutka JT, Rosenblum ML, et al: Human immunodeficiency virus can productively infect cultured human glial cells. Proc Natl Acad Sci USA 84:3526-3530, 1987
7. Corn BW, Marcus SM, Topham A, et al: Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year 2000? Cancer 79:2409-2413, 1997
8. Gasnault J, Roux FX, Vedrenne C: Cerebral astrocytoma in association with HIV infection. J Neurol Neurosurg Psychiatry 51:422-424, 1988
9. Geleziunas R, Schipper HM, Wainberg MA: Pathogenesis and therapy of HIV-1 infection of the central nervous system. AIDS 6:1411-1426, 1992 (Editorial)
10. Hajjar M, Lacoste D, Brossard G, et al: Non-acquired immune deficiency syndrome-defining malignancies in a hospital-based cohort of human immunodeficiency virus-infected patients: Bordeaux, France, 1985-1991. J Natl Cancer Inst 84: 1593-1595, 1992
11. Ho DD, Rota TR, Schooley RT, et al: Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med 313:1493-1497, 1985
12. Ho KL, Gottlieb C, Zarbo RJ: Cytomegalovirus infection of cerebral astrocytoma in an AIDS patient. Clin Neuropathol 10: 127-133, 1991
13. Holloway RG, Mushlin AI: Intracranial mass lesions in acquired immunodeficiency syndrome: using decision analysis to determine the effectiveness of stereotactic brain biopsy. Neurology 46:1010-1015, 1996
14. Iacoangeli M, Roselli R, Antinori A, et al: Experience with brain biopsy in acquired immune deficiency syndrome-related focal lesions of the central nervous system. Br J Surg 81: 1508-1511, 1994
15. Kasantikul V, Kaoroptham S, Hanvanich M: Acquired immunodeficiency syndrome associated with cerebral astrocytoma. Clin Neuropathol 11:25-27, 1992
16. Levy RM, Pons VG, Rosenblum ML: Central nervous system mass lesions in the acquired immunodeficiency syndrome (AIDS). J Neurosurg 61:9-16, 1984
17. Maxwell M, Galanopoulos T, Neville-Golden J, et al: Effect of the expression of transforming growth factor-β2 in primary human glioblastomas on immunosuppression and loss of immune surveillance. J Neurosurg 76:799-804, 1992
18. Monfardini S, Vaccher E, Pizzocaro G, et al: Unusual malignant tumours in 49 patients with HIV infection. AIDS 3:449-452, 1989
19. Moulignier A, Mikol J, Pialoux G, et al: Cerebral glial tumors and human immunodeficiency virus-1 infection. More than a coincidental association. Cancer 74:686-692, 1994
20. Nath A, Hartloper V, Furer M, et al: Infection of human fetal astrocytes with HIV-1: viral tropism and the role of cell to cell contact in viral transmission. J Neuropathol Exp Neurol 54: 320-330, 1995
21. Neal JW, Llewelyn MB, Morrison HL, et al: A malignant astrocytoma in a patient with AIDS: a possible association between astrocytomas and HIV infection. J Infect 33:159-162, 1996
22. Petty RK, Kennedy PG: The neurological features of HIV-positive patients in Glasgow - a retrospective study of 90 cases. Q J Med 82:223-234, 1992
23. Sadler M, Brink NS, Gazzard BG: Management of intracerebral lesions in patients with HIV: a retrospective study with discussion of diagnostic problems. Q J Med 91:205-217, 1998
24. Selmaj KW, Farooq M, Norton WT, et al: Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor. J Immunol 144:129-135, 1990
25. Simpson DM, Tagliati M: Neurologic manifestations of HIV infection. Ann Intern Med 121:769-785, 1994
26. Snider WD, Simpson DM, Nielsen S, et al: Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol 14:403-418, 1983
27. Tacconi L, Stapleton S, Signorelli F, et al: Acquired immune deficiency syndrome (AIDS) and cerebral astrocytoma. Clin Neurol Neurosurg 98:149-151, 1996
28. Taylor JP, Cupp C, Diaz A, et al: Activation of expression of genes coding for extracellular matrix proteins in Tat-producing glioblastoma cells. Proc Natl Acad Sci USA 89:9617-9621, 1992
29. Wahl SM, Allen JB, Hines KL, et al: Synthetic fibronectin peptides suppress arthritis in rats by interrupting leukocyte adhesion and recruitment. J Clin Invest 94:655-662, 1994